-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Transcode Therapeutics, Inc. quarterly and annual Return On Assets history and change rate from Q1 2022 to Q3 2025.
- Transcode Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -319%, a 14% decline year-over-year.
- Transcode Therapeutics, Inc. annual Return On Assets for 2024 was -287%, a 4% decline from 2023.
- Transcode Therapeutics, Inc. annual Return On Assets for 2023 was -276%, a 107% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)